Compare RNGT & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNGT | USNA |
|---|---|---|
| Founded | 2025 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.5M | 342.7M |
| IPO Year | N/A | 1996 |
| Metric | RNGT | USNA |
|---|---|---|
| Price | $10.08 | $18.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.1K | ★ 109.4K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $1,060,902,000.00 |
| Revenue This Year | N/A | $3.90 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ N/A | $42.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $16.60 |
| 52 Week High | $10.11 | $38.32 |
| Indicator | RNGT | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 55.67 | 46.46 |
| Support Level | $9.95 | $16.77 |
| Resistance Level | N/A | $18.11 |
| Average True Range (ATR) | 0.01 | 0.72 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 57.14 | 37.50 |
Range Capital Acquisition Corp II is a blank check company.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).